| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|
| M1 | ULB | 14.000 | 6.87 | YT | - | RRR- | - | - | 15.00% | - | Hxeaxipp | SIFX | - | 614 | 3zNZEI+614 | - | - |
| NC | UOV | 2.000 | 7.98 | NL | - | ZZZ- | - | - | 73.00% | - | Toknp | - | - | - | 9.64% | - | - |
| NM | UZO | 88.000 | 6.91 | ZG | - | ZZZ | - | - | 17.00% | - | Xpyojkzn | CWLO | - | 307 | 3gEDPI+307 | - | - |
| Q | AZD | 15.000 | 3.27 | UB | - | RR | - | - | 93.00% | - | Nqwlsdaq | ISVW | - | 356 | 3fJDYH+356 | - | - |
| R2O | MMJ | 73.800 | 8.28 | LA | - | L | - | - | 23.70% | - | Vfjafdee | NGEA | - | 440 | 3oCBUV+440 | - | - |
| H2F | ROA | 6.900 | 1.50 | HO | - | S | - | - | 27.00% | - | Rhquszvi | WQUC | - | 501 | 3cJIAO+501 | - | - |
| E1 | AQL | 352.000 | 8.52 | Oyy | - | KR | - | - | 85.00% | - | Idqxdazp | ZNSK | - | 239 | 3sHQKY+239 | - | - |
| F1G | KQY | 5.000 | 9.19 | SB | - | V | - | - | 76.00% | - | Wkwfyysg | ZBNB | - | 461 | 3qCTJD+461 | - | - |
| O1Z | KBI | 3.000 | 4.15 | JN | - | D | - | - | 47.00% | - | Qfxwi | - | - | - | 8.47% | - | - |
| Odr | RLZ | 71.300 | - | DN | - | DB | - | - | - | - | - | - | - | - | - | - | Retained |
Tranche Comments
E1: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144G/Klk J;
NM: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144V/Nsk M;
Q: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144O/Ive N;
R2O: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144F/Exj J;
H2F: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144M/Yfh M;
F1G: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144O/Fsm H;
O1Z: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144F/Iqs N;
M1: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144P/Ohl P;
NC: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144A/Zfy Z;
Odr: First Pay: 2023-07-20; Redemption: 2024-01-20; Registration: 144N/Ouy U;
Deal Comments
Rkb Jsoo Tofzkoy 1.00
Risk Retention
MD - Sez, Aemxype 7
WAL Test Period End Date
Jul 20, 2007